5.0
26 Aug 2025
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
Amazing intellectual atmosphere for R&D
Cons
Effectively assimilated by Roche and now just another mega-corp; pay is slightly below market rate as they see themselves as “the Harvard of industry.” Senior management makes big slash and burn cuts irrespective of contribution or potential, and pipeline is deeply questionable